Fexapotide (NX-1207) TFA selectively induces apoptosis, leading to a reduction in prostate volume at the cellular level. Fexapotide is applicable for research into lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
Formula:
C90H163N27O25S.xC2HF3O2
Target:
Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
